142 related articles for article (PubMed ID: 34633218)
1. Sulfonamide-salicylaldehyde imines active against methicillin- and trimethoprim/sulfonamide-resistant
Krátký M; Konečná K; Janoušek J; Janďourek O; Maixnerová J; Kalivodová S; Trejtnar F; Vinšová J
Future Med Chem; 2021 Nov; 13(22):1945-1962. PubMed ID: 34633218
[No Abstract] [Full Text] [Related]
2. Improving the antimicrobial activity of old antibacterial drug mafenide: Schiff bases and their bioactivity targeting resistant pathogens.
Krátký M; Konečná K; Šimková A; Janďourek O; Maixnerová J; Stolaříková J; Vejsová M; Voxová B; Trejtnar F; Vinšová J
Future Med Chem; 2023 Feb; 15(3):255-274. PubMed ID: 36891917
[No Abstract] [Full Text] [Related]
3. Sulfadiazine Salicylaldehyde-Based Schiff Bases: Synthesis, Antimicrobial Activity and Cytotoxicity.
Krátký M; Dzurková M; Janoušek J; Konečná K; Trejtnar F; Stolaříková J; Vinšová J
Molecules; 2017 Sep; 22(9):. PubMed ID: 28925956
[TBL] [Abstract][Full Text] [Related]
4. The antibacterial and anti-biofilm activity of gold-complexed sulfonamides against methicillin-resistant Staphylococcus aureus.
Mizdal CR; Stefanello ST; da Costa Flores V; Agertt VA; Bonez PC; Rossi GG; da Silva TC; Antunes Soares FA; de Lourenço Marques L; de Campos MMA
Microb Pathog; 2018 Oct; 123():440-448. PubMed ID: 30086343
[TBL] [Abstract][Full Text] [Related]
5. Novel sulfonamide derivatives as a tool to combat methicillin-resistant
Krátký M
Future Med Chem; 2024 Mar; 16(6):545-562. PubMed ID: 38348480
[TBL] [Abstract][Full Text] [Related]
6. Hybrid molecules between benzenesulfonamides and active antimicrobial benzo[d]isothiazol-3-ones.
Zani F; Incerti M; Ferretti R; Vicini P
Eur J Med Chem; 2009 Jun; 44(6):2741-7. PubMed ID: 18775586
[TBL] [Abstract][Full Text] [Related]
7. Novel Schiff base-bridged multi-component sulfonamide imidazole hybrids as potentially highly selective DNA-targeting membrane active repressors against methicillin-resistant Staphylococcus aureus.
Hu Y; Pan G; Yang Z; Li T; Wang J; Ansari MF; Hu C; Yadav Bheemanaboina RR; Cheng Y; Zhou C; Zhang J
Bioorg Chem; 2021 Feb; 107():104575. PubMed ID: 33385978
[TBL] [Abstract][Full Text] [Related]
8. Identification of antimicrobial activity among new sulfonamide metal complexes for combating rapidly growing mycobacteria.
Agertt VA; Bonez PC; Rossi GG; Flores Vda C; Siqueira Fdos S; Mizdal CR; Marques LL; de Oliveira GN; de Campos MM
Biometals; 2016 Oct; 29(5):807-16. PubMed ID: 27567903
[TBL] [Abstract][Full Text] [Related]
9. Synthesis and Antimicrobial Activity of the Hybrid Molecules between Sulfonamides and Active Antimicrobial Pleuromutilin Derivative.
Chen L; Yang D; Pan Z; Lai L; Liu J; Fang B; Shi S
Chem Biol Drug Des; 2015 Aug; 86(2):239-45. PubMed ID: 25431015
[TBL] [Abstract][Full Text] [Related]
10. Optimizing the structure of (salicylideneamino)benzoic acids: Towards selective antifungal and anti-staphylococcal agents.
Krátký M; Konečná K; Brokešová K; Maixnerová J; Trejtnar F; Vinšová J
Eur J Pharm Sci; 2021 Apr; 159():105732. PubMed ID: 33493669
[TBL] [Abstract][Full Text] [Related]
11. In Vitro Activities of LCB 01-0648, a Novel Oxazolidinone, against Gram-Positive Bacteria.
Oh SH; Kim J; Baek SY; Chae SE; Park HS; Cho YL; Kwak JH
Molecules; 2017 Mar; 22(3):. PubMed ID: 28273820
[TBL] [Abstract][Full Text] [Related]
12. Patterns of multidrug resistance among methicillin-resistant hospital isolates of coagulase-positive and coagulase-negative staphylococci collected in the international multicenter study RESIST in 1997 and 1998.
Santos Sanches I; Mato R; de Lencastre H; Tomasz A;
Microb Drug Resist; 2000; 6(3):199-211. PubMed ID: 11144420
[TBL] [Abstract][Full Text] [Related]
13. Alkoxyphenylthiazoles with broad-spectrum activity against multidrug-resistant gram-positive bacterial pathogens.
ElAwamy M; Mohammad H; Hussien A; Abutaleb NS; Hagras M; Serya RAT; Taher AT; Abouzid KA; Seleem MN; Mayhoub AS
Eur J Med Chem; 2018 May; 152():318-328. PubMed ID: 29734000
[TBL] [Abstract][Full Text] [Related]
14. Structural characterization of new Schiff bases of sulfamethoxazole and sulfathiazole, their antibacterial activity and docking computation with DHPS protein structure.
Mondal S; Mandal SM; Mondal TK; Sinha C
Spectrochim Acta A Mol Biomol Spectrosc; 2015; 150():268-79. PubMed ID: 26056977
[TBL] [Abstract][Full Text] [Related]
15. In vitro activity of taurine-5-bromosalicylaldehyde Schiff base against planktonic and biofilm cultures of methicillin-resistant Staphylococcus aureus.
Yuan R; Diao Y; Zhang W; Lin Y; Huang S; Zhang H; Ma L
J Microbiol Biotechnol; 2014 Aug; 24(8):1059-64. PubMed ID: 24759427
[TBL] [Abstract][Full Text] [Related]
16. Halogenated trimethoprim derivatives as multidrug-resistant Staphylococcus aureus therapeutics.
Nilchan N; Phetsang W; Nowwarat T; Chaturongakul S; Jiarpinitnun C
Bioorg Med Chem; 2018 Oct; 26(19):5343-5348. PubMed ID: 29784273
[TBL] [Abstract][Full Text] [Related]
17. Resistance of Staphylococcus aureus to sulphamethoxazole and trimethoprim.
Nakhla LS
J Clin Pathol; 1972 Aug; 25(8):708-12. PubMed ID: 5076806
[TBL] [Abstract][Full Text] [Related]
18. Synthesis and antimicrobial activity of novel benzoxazine sulfonamide derivatives.
Konda S; Raparthi S; Bhaskar K; Munaganti RK; Guguloth V; Nagarapu L; Akkewar DM
Bioorg Med Chem Lett; 2015 Apr; 25(7):1643-6. PubMed ID: 25754493
[TBL] [Abstract][Full Text] [Related]
19. Activity of Debio1452, a FabI inhibitor with potent activity against Staphylococcus aureus and coagulase-negative Staphylococcus spp., including multidrug-resistant strains.
Flamm RK; Rhomberg PR; Kaplan N; Jones RN; Farrell DJ
Antimicrob Agents Chemother; 2015 May; 59(5):2583-7. PubMed ID: 25691627
[TBL] [Abstract][Full Text] [Related]
20. Design and synthesis of anti-MRSA benzimidazolylbenzene-sulfonamides. QSAR studies for prediction of antibacterial activity.
González-Chávez MM; Méndez F; Martínez R; Pérez-González C; Martínez-Gutiérrez F
Molecules; 2010 Dec; 16(1):175-89. PubMed ID: 21191320
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
